Theralink Technologies Inc (THER)

[drugmanrx]

The potential market world wide for an ovarian cancer vaccine.

In people not dollars.

15-24 years: female 572,229,547)
25-54 years: female 1,488,011,505)
55-64 years: female 322,668,546)
65 years and over: female 352,206,092)

The potential market of high risk males worldwide for a prostate vaccine.

55-64 years: male 307,262,939
65 years and older male 283,540,918